[{"notes_id":"1_915","category":"1","subcategory":"0","title":"Hypertension: management","body":"NICE published updated guidelines for the management of hypertension in 2019. Some of the key changes include:<br \/><ul><li>lowering the threshold for treating stage 1 hypertension in patients < 80 years from 20% to 10%<\/li><li>angiotensin receptor blockers can be used instead of ACE-inhibitors where indicated<\/li><li>if a patient is already taking an ACE-inhibitor or angiotensin receptor blocker, then a calcium channel blocker OR a thiazide-like diuretic can be used. Previously only a calcium channel blocker was recommended<\/li><\/ul><br \/><h5 class='notes-heading'>Blood pressure classification<\/h5><br \/>This becomes relevant later in some of the management decisions that NICE advocates.<br \/><br \/><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th><b>Stage<\/b><\/th><th><b>Criteria<\/b><\/th><\/tr><\/thead><tbody><tr><td><b>Stage 1 hypertension<\/b><\/td><td>Clinic BP >= <span class=\"concept\" data-cid=\"6674\">140\/90 mmHg<\/span> and subsequent ABPM daytime average or HBPM average BP >= <span class=\"concept\" data-cid=\"6675\">135\/85 mmHg<\/span><\/td><\/tr><tr><td><b>Stage 2 hypertension<\/b><\/td><td>Clinic BP >= <span class=\"concept\" data-cid=\"6676\">160\/100 mmHg<\/span> and subsequent ABPM daytime average or HBPM average BP >= <span class=\"concept\" data-cid=\"6677\">150\/95 mmHg<\/span><\/td><\/tr><tr><td><b>Severe hypertension<\/b><\/td><td><span class=\"concept\" data-cid=\"6673\">Clinic systolic BP >= 180 mmHg, or clinic diastolic BP >= 120 mmHg<\/span><\/td><\/tr><\/tbody><\/table><\/div><br \/><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https:\/\/d32xxyeh8kfs8k.cloudfront.net\/images_Passmedicine\/pdd927b.png'><img class='ajaximage' src='https:\/\/d32xxyeh8kfs8k.cloudfront.net\/images_Passmedicine\/pdd927.png'\/><\/a><\/td><\/tr><tr><td valign='top' align='left'><\/td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https:\/\/d32xxyeh8kfs8k.cloudfront.net\/images_Passmedicine\/pdd927b.png'><img src='https:\/\/d32xxyeh8kfs8k.cloudfront.net\/css\/images\/mag_glass.png'\/><\/a><\/td><\/tr><\/table><\/CENTER><div class='imagetext'>Flow chart showing simplified schematic for diagnosis hypertension following NICE guidelines<\/div><br \/><h5 class='notes-heading'>Managing hypertension<\/h5><br \/>Lifestyle advice should not be forgotten and is frequently tested in exams:<br \/><ul><li><span class=\"concept\" data-cid=\"10294\">a low salt diet is recommended, aiming for less than 6g\/day<\/span>, ideally 3g\/day. The average adult in the UK consumes around 8-12g\/day of salt. A recent BMJ paper* showed that lowering salt intake can have a significant effect on blood pressure. For example, reducing salt intake by 6g\/day can lower systolic blood pressure by 10mmHg<\/li><li>caffeine intake should be reduced<\/li><li>the other general bits of advice remain: stop smoking, drink less alcohol, eat a balanced diet rich in fruit and vegetables, exercise more, lose weight<\/li><\/ul><br \/>ABPM\/HBPM >= <span class=\"concept\" data-cid=\"6675\">135\/85 mmHg<\/span> (i.e. stage 1 hypertension)<br \/><ul><li>treat if < 80 years of age AND any of the following apply; target organ damage, established cardiovascular disease, renal disease, diabetes or a 10-year cardiovascular risk equivalent to 10% or greater<\/li><li>in 2019, NICE made a further recommendation, suggesting that we should <i>'consider antihypertensive drug treatment in addition to lifestyle advice for adults aged under 60 with stage 1 hypertension and an estimated 10-year risk below 10%. '<\/i>. This seems to be due to evidence that QRISK may underestimate the lifetime probability of developing cardiovascular disease<\/li><\/ul><br \/>ABPM\/HBPM >= <span class=\"concept\" data-cid=\"6677\">150\/95 mmHg<\/span> (i.e. stage 2 hypertension)<br \/><ul><li>offer drug treatment regardless of age<\/li><\/ul><br \/>For patients < 40 years consider specialist referral to exclude secondary causes.<br \/><br \/><br \/><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https:\/\/d32xxyeh8kfs8k.cloudfront.net\/images_Passmedicine\/pdd566b.png'><img class='ajaximage' src='https:\/\/d32xxyeh8kfs8k.cloudfront.net\/images_Passmedicine\/pdd566.png'\/><\/a><\/td><\/tr><tr><td valign='top' align='left'><\/td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https:\/\/d32xxyeh8kfs8k.cloudfront.net\/images_Passmedicine\/pdd566b.png'><img src='https:\/\/d32xxyeh8kfs8k.cloudfront.net\/css\/images\/mag_glass.png'\/><\/a><\/td><\/tr><\/table><\/CENTER><div class='imagetext'>Flow chart showing the management of hypertension as per current NICE guideliness<\/div><br \/><br \/>Step 1 treatment<br \/><ul><li><span class=\"concept\" data-cid=\"6670\">patients < 55-years-old<\/span> or a background of <span class=\"concept\" data-cid=\"9851\">type 2 diabetes mellitus<\/span>: <b>A<\/b>CE inhibitor or a <b>A<\/b>ngiotensin receptor blocker (<b>A<\/b>CE-i or <b>A<\/b>RB): <b>(A)<\/b><ul><li><span class=\"concept\" data-cid=\"922\">angiotensin receptor blockers should be used where ACE inhibitors are not tolerated (e.g. due to a cough)<\/span><\/li><\/ul><\/li><li><span class=\"concept\" data-cid=\"6671\">patients >= 55-years-old<\/span> or of <span class=\"concept\" data-cid=\"6672\">black African or African-Caribbean origin<\/span>: <b>C<\/b>alcium channel blocker <b>(C)<\/b><ul><li><span class=\"concept\" data-cid=\"916\">ACE inhibitors have reduced efficacy in patients of black African or African-Caribbean origin are therefore not used first-line<\/span><\/li><\/ul><\/li><\/ul><br \/>Step 2 treatment<br \/><ul><li><span class=\"concept\" data-cid=\"6682\">if already taking an <b>A<\/b>CE-i or <b>A<\/b>RB add a <b>C<\/b>alcium channel blocker or a thiazide-like <b>D<\/b>iuretic<\/span><\/li><li><span class=\"concept\" data-cid=\"9850\">if already taking a <b>C<\/b>alcium channel blocker add an <b>A<\/b>CE-i or <b>A<\/b>RB or a thiazide-like <b>D<\/b>iuretic<\/span><ul><li><span class=\"concept\" data-cid=\"1386\">for patients of black African or African-Caribbean origin taking a calcium channel blocker for hypertension, if they require a second agent consider an angiotensin receptor blocker in preference to an ACE inhibitor<\/span><\/li><\/ul><\/li><li><b>(A + C) or (A + D)<\/b> or <b>(C + A) or (C + D)<\/b> <\/li><\/ul><br \/>Step 3 treatment<br \/><ul><li>add a third drug to make, i.e.:<ul><li><span class=\"concept\" data-cid=\"6683\">if already taking an <b>(A + C)<\/b> then add a <b>D<\/b><\/span><\/li><li><span class=\"concept\" data-cid=\"9849\">if already <b>(A + D)<\/b> then add a <b>C<\/b><\/span><\/li><\/ul><\/li><li><b>(A + C + D)<\/b> <\/li><\/ul><br \/>Step 4 treatment<br \/><ul><li>NICE define step 4 as resistant hypertension and suggest either adding a 4<sup>th<\/sup> drug (as below) or seeking specialist advice<\/li><li>first, check for:<ul><li>confirm elevated clinic BP with ABPM or HBPM<\/li><li>assess for postural hypotension.<\/li><li>discuss adherence<\/li><\/ul><\/li><li><span class=\"concept\" data-cid=\"6684\">if potassium < 4.5 mmol\/l add low-dose spironolactone<\/span><\/li><li><span class=\"concept\" data-cid=\"6685\">if potassium > 4.5 mmol\/l add an alpha- or beta-blocker<\/span><\/li><\/ul><br \/>Patients who fail to respond to step 4 measures should be referred to a specialist. NICE recommend:<br \/><div class='bs-callout bs-callout-default'><i><i><br \/>If blood pressure remains uncontrolled with the optimal or maximum tolerated doses of four drugs, seek expert advice if it has not yet been obtained. <br \/><\/i><\/i><\/div><br \/><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https:\/\/d32xxyeh8kfs8k.cloudfront.net\/images_Passmedicine\/pdd973b.png\" data-fancybox=\"gallery\" data-caption=\"\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https:\/\/d32xxyeh8kfs8k.cloudfront.net\/images_Passmedicine\/pdd973.png\" alt=\"\" \/><\/a><\/div><div class=\"col-md-3\"><a href=\"https:\/\/d32xxyeh8kfs8k.cloudfront.net\/images_Passmedicine\/pdd974b.png\" data-fancybox=\"gallery\" data-caption=\"\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https:\/\/d32xxyeh8kfs8k.cloudfront.net\/images_Passmedicine\/pdd974.png\" alt=\"\" \/><\/a><\/div><\/div><\/div><br \/><h5 class='notes-heading'>Blood pressure targets<\/h5><br \/><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid2\" ><thead><tr><th><\/th><th><b>Clinic BP<\/b><\/th><th><b>ABPM \/ HBPM<\/b><\/th><\/tr><\/thead><tbody><tr><td><b>Age < 80 years<\/b><\/td><td><span class=\"concept\" data-cid=\"6678\">140\/90 mmHg<\/span><\/td><td><span class=\"concept\" data-cid=\"6680\">135\/85 mmHg<\/span><\/td><\/tr><tr><td><b>Age > 80 years<\/b><\/td><td><span class=\"concept\" data-cid=\"6679\">150\/90 mmHg<\/span><\/td><td><span class=\"concept\" data-cid=\"6681\">145\/85 mmHg<\/span><\/td><\/tr><\/tbody><\/table><\/div>","notes_hash":"95248e6fb11c2374837320c9bd891a27","knowledge_graph_node_id_link":10012,"links":"<table style='width:100%'><tr><td>NICE<\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_978\" data-linkid=\"978\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"link_good_count_978\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">134<\/span><button type=\"button\" style=\"\" id=\"link_dislike_978\" data-linkid=\"978\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"link_bad_count_978\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">121<\/span><\/td><\/tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https:\/\/www.nice.org.uk\/guidance\/ng136\/chapter\/Recommendations\">2019 Hypertension guidelines<\/a><\/td><\/tr><\/table>","media":"<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/LnGB7U1xIuw\" data-description=\"Hypertension Explained\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"1380\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https:\/\/i1.ytimg.com\/vi\/LnGB7U1xIuw\/mqdefault.jpg\" style=\"max-width:150px;\"><\/a><\/td><\/tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/LnGB7U1xIuw\" data-description=\"Hypertension Explained\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"1380\">Hypertension Explained<\/a><\/td><\/tr><tr><td><span ><small>Rhesus Medicine - YouTube<\/small><\/span><\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2429\" data-mediaid=\"2429\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"media_good_count_2429\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">0<\/span><button type=\"button\" style=\"\" id=\"media_dislike_2429\" data-mediaid=\"2429\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"media_bad_count_2429\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0<\/span><\/td><\/tr><\/table>","concepts_for_notes":{"6671":{"concept_text":"Newly diagnosed patient with hypertension (> 55 years) - add a calcium channel blocker","concept_percentile":"77"}},"category_name":"All","subcategory_name":"","comment_count":16},"",[]]